{ "tag": [ "compiled" ], "id": "ocds-r6ebe6-0000485336-2017-07-14T00:00:00Z", "date": "2017-07-14T00:00:00Z", "ocid": "ocds-r6ebe6-0000485336", "initiationType": "tender", "parties": [ { "id": "org-29", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "email": "mark.salveta@nhs.net", "telephone": "+44 1312756752", "url": "http://www.publiccontractsscotland.gov.uk/Default.aspx" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } }, { "id": "org-11", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "email": "laura.santi@nhs.net", "telephone": "+44 1698794410", "url": "http://" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } } ], "buyer": { "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")", "id": "org-11" }, "tender": { "id": "NP35917", "title": "Cardiovascular & Respiratory Medicines", "description": "Medicines included in this framework agreement are generic medicines listed in the British National Formulary (BNF) used to treat cardiovascular and respiratory conditions. The Goods have been split into thirteen (13) categories, each of which is identified as a \"Lot\". Full details of each Lot is contained in section II.2 of this notice.", "status": "complete", "items": [ { "id": "3", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "3" }, { "id": "4", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "4" }, { "id": "5", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "5" }, { "id": "13", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "13" }, { "id": "6", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014" }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "6" }, { "id": "8", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "8" }, { "id": "7", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "7" }, { "id": "9", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "9" }, { "id": "10", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "10" }, { "id": "11", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "11" }, { "id": "12", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "12" }, { "id": "1", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "1" }, { "id": "2", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "2" } ], "value": { "amount": 22123563, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "goods", "submissionMethod": [ "electronicSubmission" ], "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html", "tenderPeriod": { "endDate": "2017-04-24T17:00:00Z" }, "awardPeriod": { "startDate": "2017-04-24T17:00:00Z" }, "documents": [ { "id": "MAR277762", "documentType": "contractNotice", "title": "Cardiovascular & Respiratory Medicines", "description": "Medicines included in this framework agreement are generic medicines listed in the British National Formulary (BNF) used to treat cardiovascular and respiratory conditions. The Goods have been split into thirteen (13) categories, each of which is identified as a \"Lot\". Full details of each Lot is contained in section II.2 of this notice.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR277762", "format": "text/html" }, { "id": "JUL289619", "documentType": "awardNotice", "title": "Cardiovascular & Respiratory Medicines", "description": "Medicines included in this framework agreement are generic medicines listed in the British National Formulary (BNF) used to treat cardiovascular and respiratory conditions. The Goods have been split into thirteen (13) categories, each of which is identified as a \"Lot\". Full details of each Lot is contained in section II.2 of this notice.", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL289619", "format": "text/html" } ], "lots": [ { "id": "3", "title": "Epinephrine (Adrenaline) Pre-filled Syringes", "description": "Supply of Epinephrine (Adrenaline) Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 932379, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "4", "title": "Epinephrine (Adrenaline) Auto Injector Devices", "description": "Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 321822, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "5", "title": "Fondaparinux Pre-filled Syringes", "description": "Supply of Fondaparinux Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 652914, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "13", "title": "All Other Cardiovascular & Respiratory Medicines", "description": "Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. The Authority intended to award each line within this lot to a single supplier.", "status": "complete", "value": { "amount": 13564779, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire" } }, { "id": "6", "title": "Urokinase Injections", "description": "Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 535647, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire" } }, { "id": "8", "title": "Diltiazem Hydrochloride Modified Release Capsules and Tablets", "description": "Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 102363, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "7", "title": "Isosorbide Mononitrate Modified Release Capsules and Tablets", "description": "Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 124488, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "9", "title": "Verapamil Hydrochloride Modified Release Capsules and Tablets", "description": "Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 63087, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "10", "title": "Nifedipine Modified Release Capsules and Tablets", "description": "Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 74517, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "11", "title": "Theophylline Modified Release Capsules and Tablets", "description": "Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 41373, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "12", "title": "Branded and Branded Generic Inhalers", "description": "Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.", "status": "complete", "value": { "amount": 4160520, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "1", "title": "Epoprostenol powder and solvent (pH10.5) for solution for infusion vials", "description": "Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.", "status": "complete", "value": { "amount": 1471359, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } }, { "id": "2", "title": "Epoprostenol powder and solvent (pH12) for solution for infusion vials", "description": "Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.. Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.", "status": "complete", "value": { "amount": 78315, "currency": "GBP" }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 720 }, "hasRenewal": true, "renewal": { "description": "Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire." } } ], "lotDetails": { "maximumLotsBidPerSupplier": 2147483647 }, "bidOpening": { "date": "2017-04-24T17:00:00Z" }, "contractTerms": { "hasElectronicPayment": true, "hasElectronicOrdering": true, "electronicInvoicingPolicy": "allowed" }, "coveredBy": [ "GPA" ], "selectionCriteria": { "criteria": [ { "type": "suitability", "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015" }, { "type": "technical", "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c)All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design.", "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products." } ] }, "submissionTerms": { "languages": [ "en" ], "bidValidityPeriod": { "durationInDays": 90 } }, "techniques": { "hasFrameworkAgreement": true }, "classification": { "id": "33600000", "scheme": "CPV" }, "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.", "hasRecurrence": false }, "language": "EN", "description": "The estimated values referred to in Section II.I.7 and all Lots cover the twenty-four (24) months contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:503090)", "links": [ { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000485336" }, { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000485336" } ], "noticetype": "OJEU - F3 - Contract Award Notice", "awards": [ { "id": "NP35917-1", "title": "Epoprostenol powder and solvent (pH10.5) for solution for infusion vials", "relatedLots": [ "1" ] }, { "id": "NP35917-2", "title": "Epoprostenol powder and solvent (pH12) for solution for infusion vials", "relatedLots": [ "2" ] }, { "id": "NP35917-3", "title": "Epinephrine (Adrenaline) Pre-filled Syringes", "relatedLots": [ "3" ] }, { "id": "NP35917-4", "title": "Epinephrine (Adrenaline) Auto Injector Devices", "status": "unsuccessful", "statusDetails": "unsuccessful", "relatedLots": [ "4" ] }, { "id": "NP35917-5", "title": "Fondaparinux Pre-filled Syringes", "status": "unsuccessful", "statusDetails": "unsuccessful", "relatedLots": [ "5" ] }, { "id": "NP35917-6", "title": "Urokinase Injections", "relatedLots": [ "6" ] }, { "id": "NP35917-7", "title": "Isosorbide Mononitrate Modified Release Capsules and Tablets", "relatedLots": [ "7" ] }, { "id": "NP35917-8", "title": "Diltiazem Hydrochloride Modified Release Capsules and Tablets", "relatedLots": [ "8" ] }, { "id": "NP35917-9", "title": "Verapamil Hydrochloride Modified Release Capsules and Tablets", "relatedLots": [ "9" ] }, { "id": "NP35917-10", "title": "Nifedipine Modified Release Capsules and Tablets", "relatedLots": [ "10" ] }, { "id": "NP35917-11", "title": "Theophylline Modified Release Capsules and Tablets", "status": "unsuccessful", "statusDetails": "unsuccessful", "relatedLots": [ "11" ] }, { "id": "NP35917-12", "title": "Branded and Branded Generic Inhalers", "relatedLots": [ "12" ] }, { "id": "NP35917-13", "title": "All Other Cardiovascular & Respiratory Medicines", "relatedLots": [ "13" ] } ], "contracts": [ { "id": "NP35917-1", "awardID": "NP35917-1", "title": "Epoprostenol powder and solvent (pH10.5) for solution for infusion vials", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-2", "awardID": "NP35917-2", "title": "Epoprostenol powder and solvent (pH12) for solution for infusion vials", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-3", "awardID": "NP35917-3", "title": "Epinephrine (Adrenaline) Pre-filled Syringes", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-6", "awardID": "NP35917-6", "title": "Urokinase Injections", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-7", "awardID": "NP35917-7", "title": "Isosorbide Mononitrate Modified Release Capsules and Tablets", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-8", "awardID": "NP35917-8", "title": "Diltiazem Hydrochloride Modified Release Capsules and Tablets", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-9", "awardID": "NP35917-9", "title": "Verapamil Hydrochloride Modified Release Capsules and Tablets", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-10", "awardID": "NP35917-10", "title": "Nifedipine Modified Release Capsules and Tablets", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-12", "awardID": "NP35917-12", "title": "Branded and Branded Generic Inhalers", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" }, { "id": "NP35917-13", "awardID": "NP35917-13", "title": "All Other Cardiovascular & Respiratory Medicines", "status": "active", "dateSigned": "2017-07-04T00:00:00Z" } ], "relatedProcesses": [ { "id": "1", "relationship": [ "planning" ], "scheme": "EU-OJ", "identifier": "2017/S 058-107469" } ] }